Meta Biomed Co. Ltd Cash Flow-to-Debt Ratio
Meta Biomed Co. Ltd cash flow-to-debt ratio. Meta Biomed Co. Ltd (059210) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of ₩1.05 Billion could theoretically repay 0% of its total liabilities (₩58.87 Billion) in one year. Check Meta Biomed Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Meta Biomed Co. Ltd (2011–2024)
Cash flow-to-debt ratio of Meta Biomed Co. Ltd from 2011 to 2024. Historical debt coverage capacity for Meta Biomed Co. Ltd across 14 annual periods. Check Meta Biomed Co. Ltd (059210) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Meta Biomed Co. Ltd Cash Flow-to-Debt Ratio by Year (2011–2024)
Meta Biomed Co. Ltd cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for Meta Biomed Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of Meta Biomed Co. Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | ₩22.63 Billion | ₩83.96 Billion | ▲ +51.6% |
| 2023 | 0.18x | ₩10.22 Billion | ₩57.46 Billion | ▲ +17.4% |
| 2022 | 0.15x | ₩9.16 Billion | ₩60.48 Billion | ▼ -39.1% |
| 2021 | 0.25x | ₩11.14 Billion | ₩44.80 Billion | ▲ +206.1% |
| 2020 | 0.08x | ₩4.86 Billion | ₩59.88 Billion | ▲ +41.8% |
| 2019 | 0.06x | ₩2.86 Billion | ₩50.02 Billion | ▲ +151.7% |
| 2018 | -0.11x | ₩-5.28 Billion | ₩47.72 Billion | ▼ -3180.8% |
| 2017 | 0.00x | ₩-248.51 Million | ₩73.65 Billion | ▼ -104.6% |
| 2016 | 0.07x | ₩5.03 Billion | ₩68.49 Billion | ▼ -6.3% |
| 2015 | 0.08x | ₩4.93 Billion | ₩62.91 Billion | ▲ +1975.5% |
| 2014 | 0.00x | ₩-296.24 Million | ₩70.85 Billion | ▼ -108.1% |
| 2013 | 0.05x | ₩3.71 Billion | ₩72.25 Billion | ▼ -16.1% |
| 2012 | 0.06x | ₩3.83 Billion | ₩62.54 Billion | ▼ -77.8% |
| 2011 | 0.28x | ₩4.10 Billion | ₩14.84 Billion | — |